Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis

Hematol Oncol. 2019 Aug;37(3):323-325. doi: 10.1002/hon.2617. Epub 2019 Apr 26.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Observational Study

MeSH terms

  • Aged
  • Chronic Disease
  • Databases, Factual*
  • Disease-Free Survival
  • Female
  • Humans
  • Imatinib Mesylate / administration & dosage*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Smoking / mortality*
  • Survival Rate

Substances

  • Imatinib Mesylate